Recursion Pharmaceuticals, Inc. (BMV:RXRX)

Recursion Pharmaceuticals Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	43,122	49,879	42,996	27,386	54,237	53,524
Market Cap Growth	16.03%	16.01%	57.00%	-49.51%	1.33%	-
Enterprise Value	35,016	40,588	36,543	17,999	44,895	57,318
PE Ratio	-	-4.00	-6.25	-5.67	-11.50	-4.51
PS Ratio	35.40	45.59	51.87	36.96	286.58	726.51
PB Ratio	2.49	2.59	4.99	3.03	5.37	11.89
P/TBV Ratio	34.96	1.79	4.43	2.79	3.96	1.62
P/FCF Ratio	-	-7.19	-7.71	-12.21	-14.70	-56.19
P/OCF Ratio	-	-7.47	-8.03	-17.63	-18.39	-63.40
EV/Sales Ratio	29.23	37.10	44.09	24.29	237.22	778.01
EV/EBITDA Ratio	-	-4.93	-6.03	-4.14	-13.85	-38.21
EV/EBIT Ratio	-	-4.56	-5.61	-3.94	-13.21	-36.43
EV/FCF Ratio	-4.71	-5.85	-6.56	-8.03	-12.17	-60.17
Debt / Equity Ratio	0.08	0.09	0.10	0.09	0.03	-0.09
Debt / EBITDA Ratio	-0.15	-0.24	-0.16	-0.22	-0.09	-0.23
Debt / FCF Ratio	-0.22	-0.29	-0.17	-0.42	-0.08	-0.36
Asset Turnover	0.05	0.06	0.07	0.06	0.02	0.03
Quick Ratio	3.33	3.43	4.24	5.51	11.27	11.35
Current Ratio	3.58	3.81	4.70	5.68	11.46	11.53
Return on Equity (ROE)	-66.44%	-61.89%	-69.12%	-46.56%	-110.79%	84.35%
Return on Assets (ROA)	-47.24%	-45.46%	-51.04%	-37.47%	-40.22%	-56.68%
Return on Capital (ROIC)	-81.54%	-88.78%	-152.87%	-174.66%	-279.43%	-387.36%
Return on Capital Employed (ROCE)	-54.16%	-52.59%	-60.27%	-42.20%	-43.56%	-61.43%
Earnings Yield	-28.39%	-25.00%	-16.01%	-17.64%	-8.70%	-22.17%
FCF Yield	-17.23%	-13.90%	-12.96%	-8.19%	-6.80%	-1.78%
Buyback Yield / Dilution	-8.07%	-11.50%	-6.09%	-10.49%	-16.16%	-0.02%
Total Shareholder Return	-	-11.50%	-6.09%	-10.49%	-16.16%	-0.02%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.